2019
DOI: 10.1016/j.diabet.2018.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
74
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 99 publications
(87 citation statements)
references
References 24 publications
5
74
0
1
Order By: Relevance
“…Yılmaz and others (Yılmaz et al, 2017) has shown that administration of resveratrol in drinking water to chronic MG-treated rats significantly reduces the level of advanced oxidation protein products (AOPP), AGEs, and protein carbonyl in plasma, as well as markers of oxidative stress in the liver. A significant decrease in urine albumin and creatinine and an increase in serum antioxidant enzymes were also observed in patients with type II diabetes and diabetic nephropathy who received resveratrol at the dose of 500 mg per day (Sattarinezhad et al, 2018). Resveratrol prevents opacification and formation of polyols in the bovine lens, as well as ameliorates kidney function due to suppression of AGEs formation, suggesting that resveratrol may be considered as a protective agent against diabetic complications such as cataracts and nephropathy (Ciddi & Dodda, 2014;Hussein & Mahfouz, 2016).…”
Section: Introductionmentioning
confidence: 92%
“…Yılmaz and others (Yılmaz et al, 2017) has shown that administration of resveratrol in drinking water to chronic MG-treated rats significantly reduces the level of advanced oxidation protein products (AOPP), AGEs, and protein carbonyl in plasma, as well as markers of oxidative stress in the liver. A significant decrease in urine albumin and creatinine and an increase in serum antioxidant enzymes were also observed in patients with type II diabetes and diabetic nephropathy who received resveratrol at the dose of 500 mg per day (Sattarinezhad et al, 2018). Resveratrol prevents opacification and formation of polyols in the bovine lens, as well as ameliorates kidney function due to suppression of AGEs formation, suggesting that resveratrol may be considered as a protective agent against diabetic complications such as cataracts and nephropathy (Ciddi & Dodda, 2014;Hussein & Mahfouz, 2016).…”
Section: Introductionmentioning
confidence: 92%
“…Oxyresveratrol (2′,3,4′,5-tetrahydroxystilbene), found in white mulberry ( Morus alba ), exhibited, among other effects, the inhibition of TNF-α production and stronger antioxidant activity than resveratrol [14]. Many of these molecules have been subjected to clinical trials and are being investigated as clinical drugs [15,16,17].…”
Section: Introductionmentioning
confidence: 99%
“…These results are in accordance with the results obtained by Teixeira [118] and Yang [119], who also observed a decrease in the UACR levels through administration of flavonoids in T2D patients. A later study performed by Sattarinezhad [120] also showed a decrease in the UACR when administering resveratrol. A meta-analysis performed by Liu et al [121] showed the potential renal protective effects of breviscapine (flavonoid of Erigeron breviscapus) injections, reducing urine protein, serum creatinine and blood urea nitrogen in DN patients.…”
Section: Diabetic Nephropathymentioning
confidence: 86%